Literature DB >> 3118375

Brain-type prostaglandin D synthetase occurs in the rat cochlea.

M Tachibana1, J Fex, Y Urade, O Hayaishi.   

Abstract

Prostaglandin D synthetase [(5Z, 13E)-(15S)-9 alpha, 11 alpha-epidioxy-15-hydroxyprosta-5,13-dienoate D-isomerase, EC 5.3.99.2] activity was found in the high-speed (100,000 x g, 1 hr) supernatant of the homogenate of the cochlea of adult rats. The specific activity (14.0 nmol/min per mg of protein) was 6- to 7-fold higher than that in the central nervous system. The enzyme showed full activity with 1 mM glutathione, 1 mM 2-mercaptoethanol, or 0.5 mM dithiothreitol and was almost completely inhibited by 1 mM 1-chloro-2,4-dinitrobenzene. The Km value for prostaglandin H2 was about 20 microM. These catalytic properties are the same as those of rat brain prostaglandin D synthetase but different from those of rat spleen prostaglandin D synthetase. The activity decreased to less than 20% of its initial level after incubation with excess amounts of a polyclonal or a monoclonal antibody against the brain enzyme, but the activity remained unchanged with a polyclonal antibody against the spleen enzyme, indicating that the brain-type enzyme synthesizes prostaglandin D2 in the cochlea. When cryosections of 5-week-old (adult) rat cochleas were stained by an immunoperoxidase method with antibodies against the brain enzyme, the immunoreactivity was found in inner and outer hair cells, Claudius' cells, Deiters' cells, marginal cells, basal cells, and cells of Reissner's membrane. In 8-day-old rats, the immunoreactivity was found in all of these cell types except hair cells. The immunoreactivity in hair cells was found in only one specimen from 9-day-old animals, and no immunoreactivity was found in spiral ganglion cells at any of the ages examined. These findings indicate that prostaglandin D2 is produced by the brain-type synthetase in the indicated types of cochlear cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3118375      PMCID: PMC299363          DOI: 10.1073/pnas.84.21.7677

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Stimulation of human platelet adenylate cyclase by prostaglandin D2.

Authors:  D C Mills; D E Macfarlane
Journal:  Thromb Res       Date:  1974-09       Impact factor: 3.944

4.  Prostaglandin D2 inhibits the aggregation of human platelets.

Authors:  J B Smith; M J Silver; C M Ingerman; J J Kocsis
Journal:  Thromb Res       Date:  1974-09       Impact factor: 3.944

5.  Prostaglandin D2, a neuromodulator.

Authors:  T Shimizu; N Mizuno; T Amano; O Hayaishi
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

6.  Purification and characterisation of prostaglandin endoperoxide D-isomerase, a cytoplasmic, glutathione-requiring enzyme.

Authors:  E Christ-Hazelhof; D H Nugteren
Journal:  Biochim Biophys Acta       Date:  1979-01-29

7.  The development of the stria vascularis in the mouse.

Authors:  K Kikuchi; D A Hilding
Journal:  Acta Otolaryngol       Date:  1966 Oct-Nov       Impact factor: 1.494

8.  Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species.

Authors:  B J Whittle; S Moncada; J R Vane
Journal:  Prostaglandins       Date:  1978-09

9.  Effect of prostaglandin D2 and I2 on the airways of rhesus monkeys.

Authors:  R Patterson; K E Harris; P A Greenberger
Journal:  J Allergy Clin Immunol       Date:  1980-04       Impact factor: 10.793

10.  Bronchopulmonary and cardiovascular effects of prostaglandin D2 in the dog.

Authors:  M A Wasserman; D W DuCharme; R L Griffin; G L DeGraaf; F G Robinson
Journal:  Prostaglandins       Date:  1977-02
View more
  8 in total

Review 1.  Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis.

Authors:  William L Smith; Yoshihiro Urade; Per-Johan Jakobsson
Journal:  Chem Rev       Date:  2011-09-27       Impact factor: 60.622

Review 2.  The eicosanoids and their biochemical mechanisms of action.

Authors:  W L Smith
Journal:  Biochem J       Date:  1989-04-15       Impact factor: 3.857

3.  Structural organization of the gene for prostaglandin D synthase in the rat brain.

Authors:  M Igarashi; A Nagata; H Toh; Y Urade; O Hayaishi
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

4.  Estradiol regulation of lipocalin-type prostaglandin D synthase promoter activity: evidence for direct and indirect mechanisms.

Authors:  Nino Devidze; Ko Fujimori; Yoshihiro Urade; Donald W Pfaff; Jessica A Mong
Journal:  Neurosci Lett       Date:  2010-03-01       Impact factor: 3.046

5.  Lipocalin-type prostaglandin D synthase (beta-trace) is located in pigment epithelial cells of rat retina and accumulates within interphotoreceptor matrix.

Authors:  C T Beuckmann; W C Gordon; Y Kanaoka; N Eguchi; V L Marcheselli; D Y Gerashchenko; Y Urade; O Hayaishi; N G Bazan
Journal:  J Neurosci       Date:  1996-10-01       Impact factor: 6.167

6.  Human brain prostaglandin D synthase has been evolutionarily differentiated from lipophilic-ligand carrier proteins.

Authors:  A Nagata; Y Suzuki; M Igarashi; N Eguchi; H Toh; Y Urade; O Hayaishi
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

7.  Dominant expression of mRNA for prostaglandin D synthase in leptomeninges, choroid plexus, and oligodendrocytes of the adult rat brain.

Authors:  Y Urade; K Kitahama; H Ohishi; T Kaneko; N Mizuno; O Hayaishi
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

8.  Beta-trace protein (prostaglandin D synthase)--a stable and reliable protein in perilymph.

Authors:  Olaf Michel; Stephan Bamborschke; Marko Nekic; Gregor Bachmann
Journal:  Ger Med Sci       Date:  2005-06-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.